article thumbnail

Blue Earth Diagnostics Announces Addition of POSLUMA (Flotufolastat F 18) Injection to NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer

Imaging Technology

POSLUMA is widely available through 36 radiopharmacies in the national network of Blue Earth Diagnostics’ commercial U.S. The addition of POSLUMA to the highly respected NCCN Guidelines is a major milestone for Blue Earth Diagnostics,” said David E. Chief Medical Officer of Blue Earth Diagnostics. Teoh, MBBS, MRCP, FRCR, D.Phil.,

Clinic 84
article thumbnail

Diagnosing Pediatric Crohn Disease With Radiomic and Clinical Data

Imaging Technology

milla1cf Wed, 08/02/2023 - 19:58 August 2, 2023 — An accepted manuscript published in the American Journal of Roentgenology (AJR) found that deploying a radiomic-based model with T2-weighted MRI data could increase diagnostic accuracy for pediatric Crohn disease (CD). Dillman et al.’s and accuracy of 89.6%. and accuracy of 89.6%.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

American Roentgen Ray Society Awards 2024 ARRS Gold Medal to Former President, Present Roentgen Fund Chair, Philip Costello

Imaging Technology

Gaveled in as ARRS President during the 2018 Annual Meeting in Washington, DC, presently, Dr. Costello chairs the six vital scholarship programs of ARRS’ own The Roentgen Fund—cementing dual foundations in innovation and leadership for a true diversity of radiology’s next generation.

Hospital 100
article thumbnail

Reporting the Unreported with Clinical AI: Lessons From Region Halland

Aidoc

The study featured a retrospective analysis of 1,892 cancer patients who had received CT scans between 2018 and 2019. However, many of the patients receive diagnostic scans for other reasons, which allows VCFs to be incidentally detected. Of the patients with reported VCF, only 26% were subjected to clinical management.

Clinic 59
article thumbnail

U.S. FDA Approves Blue Earth Diagnostics’ POSLUMA (Flotufolastat F 18) Injection, First Radiohybrid PSMA-targeted PET Imaging Agent for Prostate Cancer

Imaging Technology

milla1cf Tue, 05/30/2023 - 19:49 May 30, 2023 — Blue Earth Diagnostics , a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals , today announced U.S. Chief Executive Officer of Blue Earth Diagnostics. Gauden , D.Phil., The adverse reactions reported in ≥0.4%

article thumbnail

FAPI-PET shows promise for detecting pancreatic cancer

AuntMinnie

FAPI-PET imaging may become a powerful diagnostic tool for detecting pancreatic cancer, according to a study published November 16 in the Journal of Nuclear Medicine. They found high detection rates and diagnostic accuracy, as well as superior performance to standard imaging.

article thumbnail

American Roentgen Ray Society Awards 2024 ARRS Gold Medal to Former President, Present Roentgen Fund Chair, Philip Costello

Imaging Technology

Gaveled in as ARRS President during the 2018 Annual Meeting in Washington, DC, presently, Dr. Costello chairs the six vital scholarship programs of ARRS’ own The Roentgen Fund—cementing dual foundations in innovation and leadership for a true diversity of radiology’s next generation.